ADAMTS13 and acute kidney injury: These findings confirm previous data from European and US TMA registries, which reported a 44% lower proportion of acute renal failure in patients with severe ADAMTS13 deficiency [7] and a similar prevalence of 40–60% of neurological manifestations regardless of the ADAMTS13 activity level [7, 23, 24].